Revelation Biosciences Inc. (REVB)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 76
+0.04
+5.9052%
Pre Market
$
+0.02 +2.3353% 0. 78
2.97M Market Cap
- P/E Ratio
- Div Yield
20,537 Volume
- Eps
$ 0.72
Previous Close Investors:
Want to track REVB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Revelation Biosciences Inc. (REVB) Statistics
Valuation metrics
Market Cap 2.97M
Enterprise value -7.77M
Trailing P/E (ttm) -0.11
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.29
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 27.5K
Average volume (90 days) 27.18K
Price summary
52-Week low 0.71
52-Week high 5.8
Beta -
50-Day moving average 0.79
200-Day moving average 1.09
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 28 Jan 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.86%
Return on equity -1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 6.21%
Book value per share (mrq) 2.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
